S P Dix
Impact in
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Transplantation top 5%
- Renal Transplantation Outcomes and Treatments
Papers in
- Genetics 2
- Chronic Lymphocytic Leukemia Research 2
-
- Hematopoietic Stem Cell Transplantation 2
- Co-authors
- John R. WingardC. GilmoreC D HillyerLeonard T. HeffnerH. Kent HollandE. WintonDerek J. FalconerFrederick S. Nolte
- Journals
- Bone Marrow Transplantation (2 papers)Antimicrobial Agents and Chemotherapy (1 paper)Journal of Clinical Oncology (1 paper)Drugs of today (1 paper)Annals of Hematology (1 paper)
- Partner nations
- United StatesGermany
In The Last Decade
S P Dix
9 papers receiving 579 citations
Peers
Comparison fields: 5 of 75
- Hematology 256
- Transplantation 47
- Infectious Diseases 177
- Oncology 121
- Pharmacology 72
Countries citing papers authored by S P Dix
This map shows the geographic impact of S P Dix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S P Dix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S P Dix more than expected).
Fields of papers citing papers by S P Dix
This network shows the impact of papers produced by S P Dix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S P Dix. The network helps show where S P Dix may publish in the future.
Co-authorship network
The 25 scholars most cited alongside S P Dix, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Lipid formulations of amphotericin B. | 2000 | 16 |
| 2 | 1999 | 8 | |
| 3 | 1997 | 14 | |
| 4 | 1997 | 166 | |
| 5 | The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis. | 1997 | 31 |
| 6 | 1996 | 47 | |
| 7 | Association of busulfan area under the curve with veno-occlusive disease following BMT. | 1996 | 262 |
| 8 | 1996 | 14 | |
| 9 | 1985 | 37 |
About S P Dix
S P Dix is a scholar working on Genetics, Hematology, Pathology and Forensic Medicine, Pharmaceutical Science and Infectious Diseases, having authored 9 papers that have together received 595 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Polyomavirus and related diseases (2 papers), Research on Leishmaniasis Studies (1 paper), Nausea and vomiting management (1 paper) and Neutropenia and Cancer Infections (1 paper). The work is most often cited by research in Hematology (256 citations), Transplantation (47 citations), Infectious Diseases (177 citations), Oncology (121 citations) and Pharmacology (72 citations). S P Dix has collaborated with scholars based in United States and Germany. Frequent co-authors include John R. Wingard, C. Gilmore, C D Hillyer, Leonard T. Heffner, H. Kent Holland, E. Winton, Derek J. Falconer, Frederick S. Nolte, S M Devine and Robert B. Geller. Their work appears in journals such as Bone Marrow Transplantation, Antimicrobial Agents and Chemotherapy, Journal of Clinical Oncology, Drugs of today and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.